XENE

Conviction 42HealthcareScan · Thu, Sep 24, 2026

Xenon Pharmaceuticals Inc. (XENE) closed at $38.05 (+4.06%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 18, RS Rating 24, -46.4% from its 52-week high, -14.5% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

XENE$38.05+4.06%

ResistanceSupportVol 14Insider sell

Vol MA14 2.69M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Xenon Pharmaceuticals Inc.PHARMACEUTICAL PREPARATIONSwww.xenon-pharma.com ↗

Price38.05

Change+4.06%

Gap-0.64%

Rel volume1.97×

Avg volume2.06M

Avg $ vol90.16M

SMA 2053.97

SMA 5059.92

SMA 20053.28

Price vs 50-36.51%

Price vs 200-28.60%

MA stackmixed

50/200 cross—

Supertrenddown · 46.34

RSI (14)18

MACD hist-2.29

MACD cross—

Stoch %K / %D8 / 5

ADX (14)32

+DI / −DI7 / 51

RSI divergence—

MACD divergence—

ATR %7.46%

ADR %3.94%

52w high70.96

52w low36.52

From 52w high-46.39%

Above 52w low+4.18%

New 52w highNo

SqueezeOff

Bollinger width67.04%

%B0.06

Donchian pos7.13%

Donchian high63.78

Donchian low36.07

AVWAP (52w high)53.07

vs AVWAP high-28.32%

AVWAP (52w low)51.31

vs AVWAP low-25.86%

OBV trendDown

Chaikin MF (20)-0.44

Today vs 20d1.97×

Avg vol (14d)2.69M

Avg vol (20d)2.06M

Avg $ vol (20d)90.16M

Market cap3.68B

RS Rating24 / 99

RS 3m (vs SPY)-37.49%

RS 6m (vs SPY)-48.35%

RS line new highNo

Trend template3/8

Technical rank8.8

1 week-33.66%

1 month-37.03%

3 months-33.00%

6 months-31.54%

1 year+1.97%

YTD-14.49%

P/E-10.65

P/B2.97

P/S—

P/FCF-13.16

EPS-4.36

Div yield—

ROE-27.84%

ROA-26.70%

Debt/Eq0.01

Current21.02

EV/EBITDA-9.62

Gross margin—

Net margin—

Rev growth—

EPS growth-47.62%

Price target71.42

Target upside87.73%

Analyst ratingBuy

Institutional110.07%

Ent. value3.58B

Revenue264K

Net income-110.74M

Gross profit—

Free cash flow-279.92M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out96.67M

Employees370

ListedWed, Nov 5, 2014

Free float68.69M

Float %88.9%

Short interest6.34M

Days to cover9.1d

Short volume44.3%

Squeeze score61 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$1.11 vs −$1.16

Last surprise+4.3% beat

Setup gradeD

Conviction42 / 100

Pattern quality—

Tech rank8.8 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance66.05

Support57.09

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Broke out
Jul 10
1 scan
→
Breaking out now
Aug 5
1 scan
→
Broke out
Aug 6
1 scan
→
Breaking out now
Aug 26
1 scan
→
Setting up
Aug 27
1 scan

Congress activity

Disclosed STOCK Act trades in XENE

All disclosures →

No recent disclosed trades by Congress in XENE. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in XENE · open-market 5 sells

Insider	Side	Shares	Value	Traded	Filed
KENNEY CHRISTOPHER JOHN Chief Medical Officer · Common Shares · 2026-08-28	Sell	700	$43K	2026-08-28	2026-08-31
KENNEY CHRISTOPHER JOHN Chief Medical Officer · Common Shares · 2026-08-28	Sell	6.37K	$383K	2026-08-28	2026-08-31
GANNON STEVEN Director · Common Shares · 2026-08-11	Sell	10K	$641K	2026-08-11	2026-08-13
PATOU GARY Director · Common Shares · 2026-06-05	Sell	1.32K	$70K	2026-06-05	2026-06-08
PATOU GARY Director · Common Shares · 2026-06-05	Other	—	—	2026-06-05	2026-06-08
Cannon Gillian Director · Common Shares · 2026-06-05	Sell	1.19K	$63K	2026-06-05	2026-06-08
Svoronos Dawn Director · Share Option (Right to Buy) · 2026-06-03	Grant	10.51K	$0	2026-06-03	2026-06-03
Svoronos Dawn Director · Restricted Share Units · 2026-06-03	Grant	1.59K	$0	2026-06-03	2026-06-03
PATOU GARY Director · Share Option (Right to Buy) · 2026-06-03	Grant	10.51K	$0	2026-06-03	2026-06-03
Cannon Gillian Director · Share Option (Right to Buy) · 2026-06-03	Grant	10.51K	$0	2026-06-03	2026-06-03

SEC filings

EDGAR filings in XENE · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.